The Prima system, a novel implant designed to combat age-related macular degeneration (AMD), has shown significant success in restoring vision for patients with advanced cases. This system, which has received approval in Europe and is awaiting FDA clearance in the US, combines a camera-equipped eyeglass system with a retinal implant. The technology bypasses damaged photoreceptor cells by transmitting visual information directly to the brain's healthy circuitry, enabling over 80% of recipients to regain abilities like reading and using their phones. AI
IMPACT This development offers a significant advancement in treating blindness, potentially restoring functional vision for millions affected by AMD.
RANK_REASON Product launch of a novel medical device with regulatory approval in Europe and pending approval in the US. [lever_c_demoted from significant: ic=1 ai=0.1]
Read on MIT Technology Review →
- AMD
- Europe
- Frank Brodie
- Linda Marsa
- Los Angeles Times
- Prima system
- Science Corporation
- United States Food and Drug Administration
- University of California, San Francisco
- US
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →